Several miRNAs, such as miR-145, miR-21 and the miR17/92 cluster, have been associated with the disrupted BMPRII pathway in PAH and can explain the incomplete penetrance of BMPR2 mutations [89–91]). This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.